FMS-Related Tyrosine Kinase 3 Ligand Promotes Radioresistance in Esophageal Squamous Cell Carcinoma

FMS-Related Tyrosine Kinase 3 Ligand Promotes Radioresistance in Esophageal Squamous Cell Carcinoma

Aim: The FMS-related tyrosine kinase 3 ligand (FL) has an important role in regulating FMS-related tyrosine kinase 3 (Flt-3) activity. Serum FL levels are markedly increased among patients with hematopoietic disease. However, its role in radiation treatment remains unclear. In this study, we investi...

Full description

Bibliographic Details
Main Authors:	Zuoquan Zhu, Jiahang Song, Junjie Gu, Bing Xu, Xinchen Sun, Shu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Pharmacology
Subjects:	fms-related tyrosine kinase 3 ligand esophageal squamous cell carcinoma apoptosis radiotherapy DNA damage
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.659735/full

Similar Items

The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy
by: Łukasz Kuncman, et al.
Published: (2022-08-01)

Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
by: Manoj Kumar Kashyap, et al.
Published: (2018-02-01)

Relation between FMS-like tyrosine kinase 3 factor and hematological parameter in acute lymphoblastic leukemia patients by flow cytometry
by: Zainab Samir Al-Ali, et al.
Published: (2022-01-01)

Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study
by: Ahmed M. Abbas, et al.
Published: (2018-07-01)

Fms-Like Tyrosine Kinase 3-Independent Dendritic Cells Are Major Mediators of Th2 Immune Responses in Allergen-Induced Asthmatic Mice
by: Sang Chul Park, et al.
Published: (2020-12-01)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
by: Vorapong Phupong, et al.
Published: (2020-04-01)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
by: Jiawu Zhao, et al.
Published: (2024-01-01)

Soluble fms-like tyrosine kinase-1 and vascular endothelial growth factor: Novel markers for unexplained early recurrent pregnancy loss
by: Mahmoud Fathy Hassan
Published: (2014-03-01)

Microarray Analysis of Radioresistance-associated Genes in Esophageal Squamous Cell Carcinoma
by: ZHU Qingshan, et al.
Published: (2019-03-01)

The Role of Soluble fms-Like Tyrosine Kinase-1 Markers and Vascular Endothelial Growth Factor in Comparison with Color Doppler Sonography for Detecting Plasenta Accreta
by: Elhan Naghshineh, et al.
Published: (2019-05-01)

The Endothelial Glycocalyx as a Target of Excess Soluble Fms-like Tyrosine Kinase-1
by: Annika Schulz, et al.
Published: (2023-03-01)

FMS-like tyrosine kinase 3 internal tandem duplication mutation in patients with acute myeloid leukemia in Kurdistan region/Iraq
by: Sarween Sherzad Rasool, et al.
Published: (2023-01-01)

Soluble fms‐like tyrosine kinase‐1‐enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration
by: Dexun Hao, et al.
Published: (2019-10-01)

The Soluble Fms-like Tyrosine Kinase-1 Contributes to Structural and Functional Changes in Endothelial Cells in Chronic Kidney Disease
by: Annika Schulz, et al.
Published: (2022-12-01)

Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma
by: Ming-qiang Lin, et al.
Published: (2021-01-01)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
by: Nesreen Nasser, et al.
Published: (2020-12-01)

Molecular Modeling Studies of <i>N</i>-phenylpyrimidine-4-amine Derivatives for Inhibiting FMS-like Tyrosine Kinase-3
by: Suparna Ghosh, et al.
Published: (2021-11-01)

PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells
by: Won-Sik Shin, et al.
Published: (2022-02-01)

Clonal evolution of AML on novel FMS-like tyrosine kinase-3 (FLT3) inhibitor therapy with evolving actionable targets
by: Pashtoon M. Kasi, et al.
Published: (2016-01-01)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation
by: Ji Kai, et al.
Published: (2012-11-01)

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
by: Xiaofei Zhang, et al.
Published: (2018-12-01)

Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance
by: Xiufang Tian, et al.
Published: (2023-03-01)

Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma
by: Shan Huang, et al.
Published: (2023-06-01)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
by: Xinwen Chang, et al.
Published: (2023-08-01)

Interleukine-6, Vitamins A, E, and C Levels in Serum of Iraqi Patients with Fibromyalgia Syndrome (FMS)
by: Abdulnasser M. AL-Gebori
Published: (2013-01-01)

Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation
by: Yuandong Cao, et al.
Published: (2021-05-01)

Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy
by: Takumi Yanagita, et al.
Published: (2023-05-01)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021-11-01)

Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
by: Renxian Xie, et al.
Published: (2024-01-01)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
by: Xianfeng Li, et al.
Published: (2023-01-01)

Sequential boost of intensity‐modulated radiotherapy with chemotherapy for inoperable esophageal squamous cell carcinoma: A prospective phase II study
by: Xing‐Wen Fan, et al.
Published: (2020-04-01)

TOWARDS DIGITAL TWIN-DRIVEN PERFORMANCE EVALUATION METHODOLOGY OF FMS
by: Grzegorz BOCEWICZ, et al.
Published: (2022-09-01)

Case study of TCAS implementation in modern FMS
by: Anton BALABAN, et al.
Published: (2023-06-01)

Evaluation of flexibility in FMS using SAW and WPM
by: Vineet Jain, et al.
Published: (2013-10-01)

Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma
by: CHEN Lijun, WANG Yichen, ZHENG Qiang, WANG Yue, JIN Yan, LI Yuan
Published: (2023-05-01)

Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control
by: Osamu Hisano, et al.
Published: (2018-01-01)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
by: Jihui Liu, et al.
Published: (2023-03-01)

Functional Movement Screen (FMS) - kompleksowy system oceny funkcjonalnej pacjenta = Functional Movement Screen (FMS) - a comprehensive system for the functional evaluation of the patient
by: Bartosz Kochański, et al.
Published: (2015-04-01)

The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
by: Xiaofei Zhang, et al.
Published: (2021-07-01)